Literature DB >> 28204892

Vaccine-related serious adverse events might have been under-recognized in the pivotal HPV vaccine randomized trial.

Manuel Martínez-Lavín1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28204892     DOI： 10.1007/s10067-017-3575-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  2 in total

1.  A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.

Authors:  Elmar A Joura; Anna R Giuliano; Ole-Erik Iversen; Celine Bouchard; Constance Mao; Jesper Mehlsen; Edson D Moreira; Yuen Ngan; Lone Kjeld Petersen; Eduardo Lazcano-Ponce; Punnee Pitisuttithum; Jaime Alberto Restrepo; Gavin Stuart; Linn Woelber; Yuh Cheng Yang; Jack Cuzick; Suzanne M Garland; Warner Huh; Susanne K Kjaer; Oliver M Bautista; Ivan S F Chan; Joshua Chen; Richard Gesser; Erin Moeller; Michael Ritter; Scott Vuocolo; Alain Luxembourg
Journal:  N Engl J Med       Date:  2015-02-19       Impact factor: 91.245

2.  HPV vaccination syndrome. A questionnaire-based study.

Authors:  Manuel Martínez-Lavín; Laura-Aline Martínez-Martínez; Paola Reyes-Loyola
Journal:  Clin Rheumatol       Date:  2015-09-10       Impact factor: 3.650
  2 in total
  4 in total

1.  Response to "Vaccine-related serious adverse events might have been under-recognized in the pivotal HPV vaccine randomized trial".

Authors:  David Hawkes
Journal:  Clin Rheumatol       Date:  2017-03-25       Impact factor: 2.980

2.  Response to Dr. Hawkes letter regarding HPV vaccine serious adverse events.

Authors:  Manuel Martínez-Lavín
Journal:  Clin Rheumatol       Date:  2017-04-18       Impact factor: 2.980

3.  Authors' reply: Safety of Human Papillomavirus Vaccines.

Authors:  Kristine Macartney; Anastasia Phillips; Cyra Patel; Alexis Pillsbury; Julia Brotherton
Journal:  Drug Saf       Date:  2018-05       Impact factor: 5.606

Review 4.  Serious adverse events after HPV vaccination: a critical review of randomized trials and post-marketing case series.

Authors:  Manuel Martínez-Lavín; Luis Amezcua-Guerra
Journal:  Clin Rheumatol       Date:  2017-07-20       Impact factor: 3.650
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.